CIAM
GILD icon

Caitong International Asset Management’s Gilead Sciences GILD Stock Holding History

Caitong International Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,635
Closed -$201K – 2765
2025
Q4 		$201K Buy
1,635
+922
+129% +$112K 0.05% 209
2025
Q3 		$79.1K Buy
713
+410
+135% +$46.6K 0.05% 215
2025
Q2 		$33.6K Buy
+303
New +$32.2K 0.02% 363
2025
Q1 		– Sell
-1,583
Closed -$146K – 2301
2024
Q4 		$146K Buy
+1,583
New +$143K 0.14% 146

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Caitong International Asset Management's GILD Position: Q1 2026 in Review

Caitong International Asset Management sold out of Gilead Sciences (GILD) in Q1 2026, closing a stake of 1,635 shares — an estimated $201K sold.

Caitong International Asset Management first reported a position in GILD in Q4 2024 and held it in 4 quarters. The position peaked at $201K in Q4 2025. 2,320 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Caitong International Asset Management reported no remaining Gilead Sciences position as of Q1 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 1,635 Gilead Sciences shares in Q1 2026, an estimated $201K.
  • Caitong International Asset Management first reported a position in Gilead Sciences in Q4 2024 and held it in 4 quarters.
  • Caitong International Asset Management's Gilead Sciences position peaked at $201K in Q4 2025.
  • 2,320 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Caitong International Asset Management's 13F filing for Q1 2026, filed 11 May 2026.